CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: February 6, 2015
Result type: Reports
Project Number: SR0415-000
Product Line: Reimbursement Review

Generic Name: Palonosetron

Brand Name: Aloxi (capsule)

Manufacturer: Eisai Limited

Therapeutic Area: Chemotherapy-induced nausea and vomiting

Indications: Nausea and vomiting (chemotherapy induced) prevention

Submission Type: Resubmission

Project Status: Withdrawn